Hao Li
机构:Goethe University Frankfurt, Nanchang University, National Institute for Parasitic Diseases, Harbin Medical University, Sun Yat-sen University, Hunan Normal University, Second Military Medical University, Peking University, Sichuan University, Tan Tock Seng Hospital, Beijing Jishuitan Hospital, Soochow University, West China Hospital of Sichuan University, Sun Yat-sen Memorial Hospital, Third Affiliated Hospital of Harbin Medical University, First Affiliated Hospital of Xinxiang Medical University, Ningxia Medical University, The First Affiliated Hospital, Sun Yat-sen University, University Hospital Frankfurt, Sun Yat-sen University Cancer Center, Shanghai Pudong New Area Gongli Hospital, First Affiliated Hospital of Soochow University, First Affiliated Hospital of Zhengzhou University, Pudong New Area People's Hospital, First Affiliated Hospital of Nanchang University, Shenzhen Second People's Hospital, Henan Medical University, Qiqihar Medical University · ORCID:0000-0001-7191-5118
发表论文 215 篇 · 总被引 2792 次 · h-index 26
代表论文
- Adjuvant PD-1 Blockade With Camrelizumab for Nasopharyngeal Carcinoma (2025 · JAMA · 被引 66)
- Artificial intelligence for multi-time-point arterial phase contrast-enhanced MRI profiling to predict prognosis after transarterial chemoembolization in hepatocellular carcinoma (2025 · La radiologia medica · 被引 7)
- Hierarchical affinity landscape navigation through learning a shared pocket-ligand space (2025 · Patterns · 被引 5)
- Prediction of parenchymal hematoma after mechanical thrombectomy by asymmetrical prominent veins: a retrospective cohort study based on susceptibility-weighted imaging (2025 · Quantitative Imaging in Medicine and Surgery · 被引 4)
- Development and validation of a deep learning-based pathomics signature for prognosis and chemotherapy benefits in colorectal cancer: a retrospective multicenter cohort study (2025 · Frontiers in Immunology · 被引 4)
- Survival benefits of different immunotherapies for hepatocellular carcinoma: a meta-analysis highlighting age, gender, etiology, and tumor burden (2025 · Frontiers in Immunology · 被引 3)